Literature DB >> 27838622

Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?

Luke J Laffin1,2, George L Bakris1.   

Abstract

The year 2014 was a turning point for the field of renal denervation (RDN) and its potential use to treat resistant hypertension. Tremendous enthusiasm shifted to sober reflection on the efficacy of a technology once touted as the cure to resistant hypertension. The following review highlights 2 major questions: First, does catheter-based RDN lower blood pressure and, second, will RDN using catheter-directed therapy for the treatment of resistant hypertension ever become more than an investigational technology. © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; denervation; hypertension; treatment

Mesh：

Substances：

Year:  2017        PMID： 27838622      PMCID： PMC6279104          DOI： 10.1093/ajh/hpw123

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   2.689


  50 in total

1.  Externally Delivered Focused Ultrasound for Renal Denervation.

Authors:  Petr Neuzil; John Ormiston; Todd J Brinton; Zdenek Starek; Murray Esler; Omar Dawood; Thomas L Anderson; Michael Gertner; Rob Whitbourne; Roland E Schmieder
Journal:  JACC Cardiovasc Interv       Date:  2016-06-20       Impact factor: 11.195

2.  Renal innervation and renin activity in salt metabolism and hypertension.

Authors:  R A Mogil; H D Itskovitz; J H Russell; J J Murphy
Journal:  Am J Physiol       Date:  1969-04

3.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

4.  Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat.

Authors:  W V Judy; A M Watanabe; D P Henry; H R Besch; W R Murphy; G M Hockel
Journal:  Circ Res       Date:  1976-06       Impact factor: 17.367

5.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

6.  Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.

Authors:  Teba Alnima; Peter W de Leeuw; Frans E S Tan; Abraham A Kroon
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

Review 7.  Renal denervation for the treatment of resistant hypertension: review and clinical perspective.

Authors:  Radu Iliescu; Thomas E Lohmeier; Ionut Tudorancea; Luke Laffin; George L Bakris
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-29

8.  Failure of renal denervation to attenuate hypertension in Dahl NaCl-sensitive rats.

Authors:  J M Wyss; W Sripairojthikoon; S Oparil
Journal:  Can J Physiol Pharmacol       Date:  1987-12       Impact factor: 2.273

9.  Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs.

Authors:  Jeffrey R Henegar; Yongxing Zhang; Rita De Rama; Cary Hata; Michael E Hall; John E Hall
Journal:  Am J Hypertens       Date:  2014-04-06       Impact factor: 2.689

10.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321
View more
  2 in total

1.  Renal perivascular adipose tissue: Form and function.

Authors:  Carolina Baraldi A Restini; Alex Ismail; Ramya K Kumar; Robert Burnett; Hannah Garver; Gregory D Fink; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2018-02-15       Impact factor: 5.773

Review 2.  Contemporary Strategies to Manage High Blood Pressure in Patients with Coexistent Resistant Hypertension and Heart Failure With Reduced Ejection Fraction.

Authors:  Katherine Lang; Erik H Van Iterson; Luke J Laffin
Journal:  Cardiol Ther       Date:  2020-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.